Nusa Palapa Gemilang Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Nusa Palapa Gemilang Tbk. trades at Rp59 (market cap 191.17B, 23.38M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume). The key difference: Nusa Palapa Gemilang Tbk. and Brigit Biofarmaka Teknologi Tbk. are close in size by market cap, and Nusa Palapa Gemilang Tbk. is more actively traded (23.38M versus 592.2K). Which is the better fit depends on your goals.
| NPGF | OBAT | |
|---|---|---|
Market Cap | 191.17B | 172.82B |
Volume | 23.38M | 592.2K |
Lot | 233.83K | 5.92K |
Turnover | 1.38B | 147.05M |
Average Price | 59.11 | 248.31 |
Value | 1.38B | 147.05M |
Indicative Equilibrium Price | 59 | 254 |
Indicative Equilibrium Volume | 2.17K | 10 |
Trailing returns across standard periods
Latest headlines on both assets
PT Nusa Palapa Gemilang Tbk (the Company) was established based on Notarial Deed No. 111 of Untung Darmosoewirjo S.H., dated November 29, 2001, a Notary in Surabaya.
Read more on NPGF →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →